Table 1.
Characteristics of the participants in the three groups and the anesthesia and surgery performed.
| CBW Group (n = 49) | TBW Group (n = 47) | Control group (n = 22) | |
|---|---|---|---|
| Sex | |||
| Male | 18 (36.7%) | 13 (27.7%) | 7 (31.8%) |
| Female | 31 (63.3%) | 34 (72.3%) | 15 (68.2%) |
| Age (years) | 31.4 ± 7.3 | 31 ± 6.8 | 29.7 ± 6.8 |
| Weight (kg) | 132 (121.5–146.5) | 128 (118–144) | 132.5 (122.8–142) |
| Height (cm) | 169 (165–177.5) | 168 (163–174) | 168.5 (164.3–173.3) |
| BMI (kg/m2) | 44.8 (41.9–49.1) | 45.7 (42.8–48.8) | 46.5 (42.9–49.2) |
| CBW (kg) | 94. 2 (84.1–101.7) | 87.8 (83–100) | 94.2 (82.9–99.3) |
| IBW (kg) | 65 (60–77.5) | 63 (58–72) | 63.5 (59.3–73.3) |
| ASA Class | |||
| I | 9 (18.4%) | 11 (23.4%) | 7 (31.8%) |
| II | 38 (77.6%) | 35 (74.5%) | 14 (63.6%) |
| III | 2 (4.1%) | 1 (2.1%) | 1 (4.5%) |
| Duration of anesthesia (minutes) | 114 (92.5–160.5) | 115 (92–140) | 190.5 (175–221.3)*** |
| Duration of surgery (minutes) | 97 (72.5–128.5) | 95 (70–119) | 90 (75–118.5) |
| Rocuronium dose (mg) | 156 (138–180) | 163 (134–183) | 155.5 (142.3–173.5) |
| Sugammadex dose (mg) | 377 (336.4–406.8) | 512 (472–576)### | ——— |
The CBW group was administered 4 mg/kg sugammadex, calculated on a CBW basis; the TBW group was administered 4 mg/kg sugammadex, calculated on a TBW basis; and the Control group was not administered this drug. Data are expressed as median (interquartile range), mean ± SD, or number of patients (%). ***P<0.001 compared with the CBW group and the TBW group (Kruskal–Wallis test) and ###P<0.001 compared with the CBW group (Mann–Whitney U-test).
CBW, corrected body weight; TBW, total body weight, IBW, ideal body weight.